|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Kaplan Medical Center |
|---|---|
| Information provided by: | Kaplan Medical Center |
| ClinicalTrials.gov Identifier: | NCT00373919 |
Purpose
Cervical anastomotic leak is one of the most common complications after trans-hiatal esophagectomy.
Hypothesis: An early post operative administration of a pro-kinetic dosage of erythromycin will reduce leak occurrence.
Design: This is a prospective, randomized, double blind, placebo controlled study.
Number of patients: 30.
Inclusion Criteria:
Exclusion Criteria:
| Condition | Intervention |
|---|---|
|
Esophagectomy Postoperative Complications |
Drug: intravenous (IV) administration of erythromycin |
| Study Type: | Interventional |
| Study Design: | Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Yoram Klein, MD | 972-50-8213221 | yoramkl@clalit.org.il |
| Principal Investigator: | Koram Klein, MD | Kaplan Medical Center |
More Information
| Study ID Numbers: | erythro-esophagus |
| Study First Received: | September 7, 2006 |
| Last Updated: | March 2, 2007 |
| ClinicalTrials.gov Identifier: | NCT00373919 |
| Health Authority: | Israel: Ministry of Health |
|
Erythromycin stearate Erythromycin Estolate Esophageal disorder Postoperative Complications |
Erythromycin Ethylsuccinate Esophageal Diseases Erythromycin |
|
Anti-Infective Agents Anti-Bacterial Agents Protein Synthesis Inhibitors Pathologic Processes Molecular Mechanisms of Pharmacological Action |
Therapeutic Uses Gastrointestinal Agents Enzyme Inhibitors Pharmacologic Actions |
